FDA Import Refusal AEK-7754769-1/20002/1 — Glaxosmithkline
The FDA refused shipment AEK-7754769-1/20002/1 from Glaxosmithkline (United Kingdom) on Oct 24, 2025. The refused product falls under Drugs and Biologics — LAMOTRIGINE (ANTI-CONVULSANT). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 24, 2025
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61MDA38 LAMOTRIGINE (ANTI-CONVULSANT)
- Charges
- 118,3280